*Disseminated on Behalf of Maia Biotechnology, Inc. Please see disclosures below. |
| Reasons to Look Into Maia Biotechnology |
| | | | | Hey Folks, Here are five reasons why Maia Biotechnology, Inc. (MAIA) may be worth paying attention to:
1. First-in-Class Mechanism — Maia's telomere-targeting approach is novel and differentiated from existing cancer treatments, addressing a biological vulnerability that roughly 85 to 90% of cancers rely on to survive. 2. Significant Unmet Medical Need — Third-line NSCLC patients who have failed both chemotherapy and immunotherapy have extremely limited options, with standard of care overall survival sitting at roughly 6 months. 3. Massive Market Opportunity — NSCLC accounts for approximately 80% of all lung cancers, with analysts estimating the therapeutics market could reach $50 to $66 billion by the early 2030s. 4. Encouraging Phase 2 Data — The THIO-101 trial reported progression-free survival of 5.6 months versus the 2.5-month standard of care benchmark, and estimated median overall survival of 17.8 months. 5. Pivotal Phase 3 Trial Underway — The THIO-104 trial dosed its first patient in December 2025, comparing Maia's lead candidate plus a checkpoint inhibitor versus chemotherapy in up to 300 patients with overall survival as the primary endpoint.
Anyways...
That's all for now!
Until Next Time, -ZT Team | P.S. Want our text alerts? Text "ZIPTRADER" to 1-(855)-228-1598 to sign up!
(standard carrier data/text rates apply) |
|
|
|---|
|
*Disseminated on Behalf of Maia Biotechnology, Inc. Please see disclosures below. |
|
|---|
|
| | 5101 SANTA MONICA BLVD STE 8 #62, 90029, LOS ANGELES, CA |
| This email was sent to punjabsvera@gmail.com |
| *SPONSORED CONTENT* ZipTrader LLC is a publishing company, we are not financial advisors. This is not financial advice. Investments involve risk and are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance. ZipTrader has been compensated thirty-four thousand USD by ACH Bank Transfer by TD Media LLC to distribute media via YouTube, email, and SMS on behalf of Maia Biotechnology, Inc. (MAIA) from March 26, 2026 to March 27, 2026. ZipTrader has been compensated twenty five thousand USD by ACH Bank Transfer by TD Media LLC for this sponsorship on YouTube on behalf of Maia Biotechnology Inc (MAIA) for January 26th 2026. ZipTrader has been compensated twenty-three thousand USD by ACH Bank Transfer by Lifewater Media to distribute media via email and SMS for MAIA Biotechnology, Inc. (MAIA) on January 13, 2025. ZipTrader has been compensated an additional four thousand USD to distribute media on Discord for MAIA Biotechnology, Inc. (MAIA) on January 13, 2025. ZipTrader has been compensated thirty-four thousand USD by ACH Bank Transfer by Lifewater Media to distribute media via email, SMS, Discord, X/Twitter, Facebook, and YouTube for MAIA Biotechnology, Inc. (MAIA) from December 16, 2024 through December 17, 2024. ZipTrader has been compensated seventeen thousand five hundred USD by ACH Bank Transfer by Lifewater Media to distribute media via email and SMS for MAIA Biotechnology, Inc. (MAIA) from February 21, 2024 through February 22, 2024. ZipTrader has been compensated eleven thousand two hundred and fifty USD by ACH Bank Transfer by Lifewater Media to distribute media via email and SMS for MAIA Biotechnology, Inc. (MAIA) from November 10, 2023 through November 11, 2023. ZipTrader has been compensated eighteen thousand USD by ACH Bank Transfer by Lifewater Media to distribute media via YouTube for MAIA Biotechnology, Inc. (MAIA) from October 24, 2023 through October 25, 2023. ZipTrader has been compensated fifteen thousand USD by ACH Bank Transfer by Lifewater Media to distribute media via email and SMS for MAIA Biotechnology, Inc. (MAIA) from October 4, 2023 through October 5, 2023. As a result of this advertisement and other marketing efforts, ZipTrader may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of ZipTrader do not hold a position in MAIA Biotechnology, Inc. (MAIA). This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of MAIA Biotechnology, Inc. (MAIA), increased trading volume, and possibly an increased share price of MAIA Biotechnology, Inc. (MAIA), which may or may not be temporary and decrease once the marketing arrangement has ended. |
| BY READING THIS EMAIL & ALL ZIPTRADER CONTENT YOU AGREE: This is not financial advice. You must do your own due diligence on all information. ZIPTRADER LLC is a publishing company and we provide general information, opinions, & news coverage to viewers. However – we do not provide personalized financial advice, are not financial advisors, and our opinions are not suitable for all investors. You should not treat any opinion as expressed as a specific inducement to make a particular investment or follow a particular strategy, but just as an opinion. Use at your own risk. Past Performance is not indicative of future results, and any results presented are not typical, and should not be understood as typical. Actual results vary given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. TRADING IS RISKY: Most traders in all markets lose all of their money (and more if they use margin). Most small businesses fail. Do NOT partake in trading, investing, entrepreneurship or any other risky endeavor covered here if you are not prepared with the reality that most fail. We reserve the right to have affiliate relationships with advertisers/sponsors. See Full Terms of Service. See Our Advertisement Disclaimer. |
| | |
|
|
|---|
|
|
|
